ANIMALS IN THE ROOM LIMITED
Opportunity 71/100 (strong), bankability 65/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (73/100).
Data confidence
Overall: low (51/100)Sparse data coverage. Treat AI-generated outputs as preliminary. Manual diligence essential.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Recent activity
Corporate timeline (5 events)Click to expand
- 2025-07-04🏢Company incorporatedAs ANIMALS IN THE ROOM LIMITED
- 2025-07-04➕JAMES, Benjamin David appointedsecretary
- 2025-07-04➕CHALLENGER, Melanie Challenger Elisabeth appointeddirector
- 2025-07-04➕RYAN, Erin Ryan Bridget, Dr appointeddirector
- 2025-07-04📄incorporation-companyincorporation · NEWINC
Owner dependency
Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
- +Young company: Only 1.0 years old — management layer unlikely to be developed.
Succession & seller-readiness
Limited succession signal. Not a near-term off-market candidate.
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
Red flags
cleanShareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Ms Melanie Challenger Elisabeth Challenger Individual · British · DOB 09/1976 · age 50 | — | 25–50% | 25-50% voting | 04/07/2025 |
Dr Erin Ryan Bridget Ryan Individual · Canadian · DOB 08/1977 · age 49 | — | 25–50% | 25-50% voting | 04/07/2025 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · EC postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| A PERFECT JOB LIMITED→ 09445470 · est 2015 · no financials extracted | — | — | — | — | 11y | — | — |
| AMIA LABS LIMITED→ 15981283 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| AMICURA SCARBOROUGH LIMITED→ 11510160 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| ANCHOR POINT CARE SERVICES LTD→ 16603091 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ANDROMEDA FOUNDATION→ 14134003 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| ANGLO JAPANESE GLOBAL HEALTH LIMITED→ 10946706 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| ANIMAL SURVIVAL INTERNATIONAL LIMITED→ 02565899 · est 1990 · no financials extracted | — | — | — | — | 35y | — | — |
| ANNUR MEDICAL LTD→ 15413369 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| ANSA THERAPIES LTD→ 16701180 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ANT MEDICAL PA LTD→ 16615310 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ANTERIDES LTD→ 09530696 · est 2015 · no financials extracted | — | — | — | — | 11y | — | — |
| ANTON CARE SERVICES LIMITED→ 16973646 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (3 active · 0 resigned)
Click a director name to see their full track record across all companies.